Cardiocomm Solutions Stock Short Ratio
| EKGGF Stock | USD 0.01 0.00 0.00% |
CardioComm Solutions fundamentals help investors to digest information that contributes to CardioComm Solutions' financial success or failures. It also enables traders to predict the movement of CardioComm Pink Sheet. The fundamental analysis module provides a way to measure CardioComm Solutions' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to CardioComm Solutions pink sheet.
CardioComm |
CardioComm Solutions Company Short Ratio Analysis
CardioComm Solutions' Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.
The higher the Short Ratio, the longer it would take to buy back the borrowed shares. In theory, the more short positions are currently outstanding, the faster it will be to cover shorted positions.
| Competition |
Based on the latest financial disclosure, CardioComm Solutions has a Short Ratio of 0.0 times. This is 100.0% lower than that of the Health Care Technology sector and about the same as Health Care (which currently averages 0.0) industry. The short ratio for all United States stocks is 100.0% higher than that of the company.
Did you try this?
Run Equity Valuation Now
Equity ValuationCheck real value of public entities based on technical and fundamental data |
| All Next | Launch Module |
CardioComm Fundamentals
| Return On Asset | 0.16 | |||
| Profit Margin | 0.28 % | |||
| Operating Margin | 0.08 % | |||
| Current Valuation | 1.82 M | |||
| Shares Outstanding | 151.16 M | |||
| Shares Owned By Insiders | 37.74 % | |||
| Price To Sales | 1.62 X | |||
| Revenue | 682.51 K | |||
| Gross Profit | 734.6 K | |||
| EBITDA | 61.24 K | |||
| Net Income | 283 | |||
| Cash And Equivalents | 153.45 K | |||
| Total Debt | 413.81 K | |||
| Debt To Equity | 430.30 % | |||
| Current Ratio | 0.59 X | |||
| Book Value Per Share | (0) X | |||
| Cash Flow From Operations | (120.8 K) | |||
| Number Of Employees | 16 | |||
| Beta | -0.25 | |||
| Market Capitalization | 1.69 M | |||
| Total Asset | 486.47 K | |||
| Z Score | 3.4 | |||
| Net Asset | 486.47 K |
About CardioComm Solutions Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze CardioComm Solutions's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of CardioComm Solutions using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of CardioComm Solutions based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in CardioComm Pink Sheet
CardioComm Solutions financial ratios help investors to determine whether CardioComm Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in CardioComm with respect to the benefits of owning CardioComm Solutions security.